Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
出版年份 2021 全文链接
标题
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
作者
关键词
Neoplasms, Haematologic neoplasms, COVID-19 vaccines, SARS-CoV-2, Immunogenicity, Vaccines, COVID-19 breakthrough infections
出版物
EUROPEAN JOURNAL OF CANCER
Volume 160, Issue -, Pages 243-260
出版商
Elsevier BV
发表日期
2021-10-27
DOI
10.1016/j.ejca.2021.10.014
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
- (2021) R. Palich et al. ANNALS OF ONCOLOGY
- Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey
- (2021) J. Barrière et al. ANNALS OF ONCOLOGY
- Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors
- (2021) J. Barrière et al. ANNALS OF ONCOLOGY
- Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
- (2021) Yair Herishanu et al. BLOOD
- Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
- (2021) Fulvia Pimpinelli et al. Journal of Hematology & Oncology
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
- (2021) Aakash Desai et al. Nature Reviews Clinical Oncology
- Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
- (2021) Sarah Bird et al. Lancet Haematology
- BNT162b2 COVID ‐19 vaccine is significantly less effective in patients with hematologic malignancies
- (2021) Katrin Herzog Tzarfati et al. AMERICAN JOURNAL OF HEMATOLOGY
- Impaired response to first SARS‐CoV ‐2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib
- (2021) Paola Guglielmelli et al. AMERICAN JOURNAL OF HEMATOLOGY
- Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
- (2021) William A. Werbel et al. ANNALS OF INTERNAL MEDICINE
- Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients
- (2021) P. Heudel et al. ANNALS OF ONCOLOGY
- Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies
- (2021) Paola Ghione et al. BLOOD
- Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia
- (2021) Patrick Harrington et al. BRITISH JOURNAL OF HAEMATOLOGY
- Serological SARS‐CoV‐2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID‐19 vaccine in haematological and oncological patients
- (2021) Magdalena Benda et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impaired antibody response to COVID‐19 vaccination in patients with chronic myeloid neoplasms
- (2021) Onima Chowdhury et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient
- (2021) Joshua A. Hill et al. CANCER CELL
- Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
- (2021) Alfredo Addeo et al. CANCER CELL
- Seroconversion rates following COVID-19 vaccination among patients with cancer
- (2021) Astha Thakkar et al. CANCER CELL
- Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
- (2021) Lee M. Greenberger et al. CANCER CELL
- Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer
- (2021) Sidse Ehmsen et al. CANCER CELL
- Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
- (2021) Elizabeth A. Griffiths et al. CANCER CELL
- The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience
- (2021) Gabriel Revon-Riviere et al. EUROPEAN JOURNAL OF CANCER
- Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy
- (2021) Cengiz Karacin et al. Future Oncology
- Safety and efficacy of BNT162b mRNA Covid19 Vaccine in patients with chronic lymphocytic leukemia
- (2021) Ohad Benjamini et al. HAEMATOLOGICA
- Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
- (2021) Ilies Benotmane et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia
- (2021) Fulvia Pimpinelli et al. Journal of Hematology & Oncology
- Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
- (2021) Xinxue Liu et al. LANCET
- Response to mRNA vaccination for COVID-19 among patients with multiple myeloma
- (2021) Samuel D. Stampfer et al. LEUKEMIA
- Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
- (2021) Tina Schmidt et al. NATURE MEDICINE
- A French cohort for assessing COVID-19 vaccine responses in specific populations
- (2021) Paul Loubet et al. NATURE MEDICINE
- Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
- (2021) Joana Barros-Martins et al. NATURE MEDICINE
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
- (2021) Johan Normark et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
- (2021) Victoria G. Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
- (2021) Florent Malard et al. Blood Cancer Journal
- Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia
- (2021) H. Parry et al. Blood Cancer Journal
- Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
- (2021) Vincent C Marconi et al. Lancet Respiratory Medicine
- Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study
- (2021) Kazimieras Maneikis et al. Lancet Haematology
- Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
- (2021) Sean H Lim et al. Lancet Haematology
- Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer
- (2021) Cynthia Villarreal-Garza et al. JAMA Oncology
- Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
- (2021) Amir Massarweh et al. JAMA Oncology
- Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
- (2021) Tal Goshen-Lago et al. JAMA Oncology
- Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment
- (2021) Susanne Ghandili et al. Cancers
- Emerging issues related to COVID-19 vaccination in patients with cancer
- (2021) Kamal S. Saini et al. Oncology and Therapy
- mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
- (2021) Sjoukje F Oosting et al. LANCET ONCOLOGY
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
- (2020) Marina Chiara Garassino et al. LANCET ONCOLOGY
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis
- (2020) Evandro de Azambuja et al. ESMO Open
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
- (2020) Antoni Ribas et al. Cancer Discovery
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now